Literature DB >> 33370070

Platelet-Rich Plasma: Evolving Role in Plastic Surgery.

Edward S Chamata1, Erica L Bartlett1, David Weir1, Rod J Rohrich1.   

Abstract

BACKGROUND: The use of platelet-rich plasma has emerged as one of the most desired nonsurgical treatments for facial rejuvenation and hair restoration. It has grown to encompass a wide variety of applications within the field of plastic surgery, including its use in combination with microneedling, laser, and fat-grafting procedures.
METHODS: In this article, the authors aim to (1) describe the preparation process of platelet-rich plasma; (2) discuss the proposed science behind platelet-rich plasma with regard to its evolving role in hair restoration and facial rejuvenation; and (3) highlight the recent literature examining its widespread use.
RESULTS: Based on the available literature, there is a therapeutic advantage to the use of platelet-rich plasma as a single treatment modality for alopecia and skin rejuvenation and in combination with laser skin treatment and fat grafting. There is, however, a considerable amount of variability in the processing, preparation, and treatment modalities.
CONCLUSIONS: Despite a lack of standardized protocols for platelet-rich plasma preparation and a scarcity of large-scale studies with long-term follow-up, there is convincing evidence with objective measurement modalities that display positive outcomes after treatment for skin rejuvenation, hair regrowth, wound healing, and fat graft take.
Copyright © 2020 by the American Society of Plastic Surgeons.

Entities:  

Mesh:

Year:  2021        PMID: 33370070     DOI: 10.1097/PRS.0000000000007509

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  1 in total

1.  Platelet-Rich Plasma in Plastic Surgery: A Systematic Review.

Authors:  Sophie K Hasiba-Pappas; Alexandru Cristian Tuca; Hanna Luze; Sebastian P Nischwitz; Robert Zrim; Judith C J Geißler; David Benjamin Lumenta; Lars-P Kamolz; Raimund Winter
Journal:  Transfus Med Hemother       Date:  2022-05-02       Impact factor: 4.040

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.